Plasma Cytokine And Angiogenic Factors (Cafs) Predictive Of Clinical Benefit And Prognosis In Patients (Pts) With Advanced Or Metastatic Renal Cell Cancer (Mrcc) Treated In Phase Iii Trials Of Pazopanib (Pazo)
JOURNAL OF CLINICAL ONCOLOGY(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要